BioPharma Credit PLC
BOPCF
$0.96
$0.011.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 129.89M | 126.51M | 123.12M | 122.65M | 122.18M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -17.55M | -14.47M | -11.39M | -5.65M | 92.00K |
| Change in Net Operating Assets | -21.24M | -17.47M | -13.71M | -12.03M | -10.36M |
| Cash from Operations | 91.10M | 94.56M | 98.03M | 104.97M | 111.91M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 77.48M | 73.74M | 70.00M | 54.54M | 39.07M |
| Cash from Investing | 77.48M | 73.74M | 70.00M | 54.54M | 39.07M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -51.27M | -65.79M | -80.31M | -93.03M | -105.75M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -79.96M | -68.30M | -56.65M | -82.83M | -109.02M |
| Other Financing Activities | -30.42M | -47.18M | -63.93M | -64.79M | -65.64M |
| Cash from Financing | -161.65M | -181.27M | -200.89M | -240.65M | -280.42M |
| Foreign Exchange rate Adjustments | 37.00K | 30.00K | 23.00K | 10.50K | -2.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.97M | -12.94M | -32.84M | -81.14M | -129.43M |